Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-13 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 5,750,882 | 4.2% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Denali Therapeutics Inc. | 10,834,483 | 7.8% | EDGAR |
SC 13G/A | 2024-02-12 | BIOGEN INC. | Denali Therapeutics Inc. | 12,751,365 | - | EDGAR |
SC 13G | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Denali Therapeutics Inc. | 7,274,717 | 5.3% | EDGAR |
SC 13G/A | 2024-01-30 | BAILLIE GIFFORD & CO | Denali Therapeutics Inc. | 14,260,724 | 10.3% | EDGAR |
SC 13G/A | 2024-01-30 | Temasek Holdings (Private) Ltd | Denali Therapeutics Inc. | 6,895,992 | 4.9% | EDGAR |
SC 13G/A | 2024-01-25 | BlackRock Inc. | Denali Therapeutics Inc. | 11,542,861 | 8.4% | EDGAR |
SC 13G | 2023-03-30 | Temasek Holdings (Private) Ltd | Denali Therapeutics Inc. | 6,895,992 | 5.0% | EDGAR |
SC 13G/A | 2023-02-13 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 7,000,882 | 5.2% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Denali Therapeutics Inc. | 5,854,035 | 4.3% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Denali Therapeutics Inc. | 9,947,098 | 7.3% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | Denali Therapeutics Inc. | 9,321,429 | 6.9% | EDGAR |
SC 13G/A | 2023-01-20 | BAILLIE GIFFORD & CO | Denali Therapeutics Inc. | 15,119,474 | 11.1% | EDGAR |
SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Denali Therapeutics Inc. | 4,635,433 | 3.7% | EDGAR |
SC 13G/A | 2022-02-14 | BRATTON DOUGLAS K | Denali Therapeutics Inc. | 7,845,189 | 6.4% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | Denali Therapeutics Inc. | 6,592,033 | 5.4% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Denali Therapeutics Inc. | 8,161,530 | 6.7% | EDGAR |
SC 13G/A | 2022-02-08 | ARCH Venture Fund VIII, L.P. | Denali Therapeutics Inc. | - | - | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Denali Therapeutics Inc. | 8,110,822 | 6.6% | EDGAR |
SC 13G/A | 2022-01-18 | BAILLIE GIFFORD & CO | Denali Therapeutics Inc. | 15,056,381 | 12.3% | EDGAR |